EVALUATION OF AN ORAL-CONTRACEPTIVE CONTAINING 0.150-MG DESOGESTREL AND 0.020-MG ETHINYLESTRADIOL IN WOMEN AGED 30 YEARS OR OLDER

被引：0

|

作者：

STEFFENSEN, K

机构：

来源：

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA | 1987年

关键词：

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

收藏

页码：23 / 27

页数：5

相关论文

共 39 条

[1] BELGIAN TRIAL OF AN ORAL-CONTRACEPTIVE CONTAINING 0.150-MG DESOGESTREL AND 0.020-MG ETHINYLESTRADIOL
VANKETS, HE
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, : 13 - 17
[2] GERMAN TRIAL OF AN ORAL-CONTRACEPTIVE CONTAINING 0.150-MG DESOGESTREL PLUS 0.020-MG ETHINYLESTRADIOL
NEVINNYSTICKEL, J
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, : 19 - 21
[3] CLIMACTERIC SYMPTOMS AND CONTROL OF THE CYCLE IN WOMEN AGED 35 YEARS OR OLDER TAKING AN ORAL-CONTRACEPTIVE WITH 0.150-MG DESOGESTREL AND 0.020-MG ETHINYLESTRADIOL
TROSSARELLI, GF
GENNARELLI, G
BENEDETTO, C
DEALOYSIO, D
MAULONI, M
FANIZZA, G
COVELLI, A
[J]. CONTRACEPTION, 1995, 51 (01) : 13 - 18
[4] EFFECTS OF THE ORAL-CONTRACEPTIVE COMBINATION 0.150-MG DESOGESTREL +0.020-MG ETHINYLESTRADIOL ON SERUM-LIPIDS INCLUDING THE HDL SUBFRACTIONS
KLOOSTERBOER, HJ
VANWAYJEN, RGA
VANDENENDE, A
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, : 33 - 36
[5] EFFECTS OF THE ORAL-CONTRACEPTIVE COMBINATION 0.150-MG DESOGESTREL PLUS 0.020-MG ETHINYLESTRADIOL ON CARBOHYDRATE-METABOLISM IN HEALTHY FEMALE VOLUNTEERS
VANDENENDE, A
LUTJENS, A
VANWAYJEN, RGA
KLOOSTERBOER, HJ
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, : 29 - 32
[6] A CLINICAL COMPARISON IN FINLAND OF 2 ORAL-CONTRACEPTIVES CONTAINING 0.150-MG DESOGESTREL IN COMBINATION WITH 0.020-MG OR 0.030-MG ETHINYLESTRADIOL
TUIMALA, R
SARANEN, M
ALAPIESSA, U
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, : 7 - 12
[7] EFFECTS OF THE ORAL-CONTRACEPTIVE COMBINATION 0.150-MG DESOGESTREL +0.020-MG ETHINYLESTRADIOL ON SERUM-LIPIDS, SHBG, GLYCOSYLATED PROTEINS AND PLASMA ANTITHROMBIN-III ACTIVITY IN HEALTHY WOMEN
TUIMALA, R
KORHONEN, M
KORTESLUOMA, M
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, : 37 - 39
[8] SCANDINAVIAN TRIAL OF AN ORAL-CONTRACEPTIVE CONTAINING 0.150 MG DESOGESTREL AND 0.030 MG ETHINYLESTRADIOL
BORGLIN, NE
CHRISTENSEN, OJE
CULLBERG, G
ENGER, L
FJAERESTAD, I
KLOTTRUP, P
ODLIND, V
SANDAGER, T
SECHER, K
ASSENDORP, R
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1982, : 39 - 42
[9] CLINICAL-STUDIES WITH A NEW, LOW-DOSE ORAL-CONTRACEPTIVE COMBINATION, CONTAINING 0.150 MG DESOGESTREL AND 0.020 MG ETHINYLESTRADIOL - FOREWORD
ALAPIESSA, U
LOK, D
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, : 5 - 5
[10] EFFECTS OF AN ORAL-CONTRACEPTIVE COMBINATION CONTAINING 0.150 MG DESOGESTREL PLUS 0.020 MG ETHINYL ESTRADIOL ON HEALTHY PREMENOPAUSAL WOMEN
DEALOYSIO, D
MAULONI, M
RONCUZZI, A
ALTIERI, P
BOTTIGLIONI, F
TROSSARELLI, GF
FANIZZA, G
COVELLI, A
[J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1993, 253 (01) : 15 - 19

← 1 2 3 4 →